Skip to main content
. 2018 May 23;8:8056. doi: 10.1038/s41598-018-26450-0

Table 2.

IC50 values of well-known and new compounds against hPARP1, PdPARP and HaPARP.

Compound hPARP1 CdPARP HaPARP
Literature IC50 (nM) IC50 (nM) IC50 (µM) IC50 (µM)
Rucaparib 1.456 12.1 ± 1.7 5.3 ± 0.7 7.2 ± 0.7
ABT-888 5.257 21.0 ± 1.9 >50 >50
PJ-34 2058 34.5 ± 3.1 32.4 ± 9.8 50.4 ± 6.4
EB-47 4547 37.2 ± 4.9 0.86 ± 0.07 1.0 ± 0.1
DPQ 4059 73.8 ± 8.2 25.3 ± 7.1 >50
7655698 81.2 ± 21.3
7650649 136.1 ± 41.1
7651361 168.2 ± 44.1
7642078 181.9 ± 21.4
4-amino 1.8-naphthalimide 18060 247.6 ± 35.9
7669941 308.4 ± 21.3
7670490 403.7 ± 53.4
7650155 458.9 ± 74.7
7660328 481.3 ± 30.1
TIQ-A 45061 596.3 ± 31.4 15.7 ± 4.1 7.9 ± 1.7
9019116 676.8 ± 32.7
XAV-939 220062 726.2 ± 156.1 >50 >50

Literature values are from different authors47,5662.